CORT Q3 2019 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$82M+26.5% YoY

Gross Profit

$80M98.2% margin

Operating Income

$33M40.5% margin

Net Income

$26M32.3% margin

EPS (Diluted)

$0.22

QoQ Revenue Growth

+12.8%

Cash Flow

Operating Cash Flow

$38M

Free Cash Flow

$38M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$367M

Total Liabilities

$33M

Stockholders' Equity

$334M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$64M	+26.5%
Gross Profit	$80M	$63M	+26.8%
Operating Income	$33M	$23M	+43.7%
Net Income	$26M	$18M	+48.4%